CytoSorb® Reduction of Free Hemoglobin during Cardiac Surgery(REFRESH Trial)

Surgery, Heart
Richard Engelman, MD

Baystate Medical Center

759 Chestnut Street

Springfield, MA  01199

The purpose of this study is to evaluate the safety and performance of the CytoSorb®device to reduce plasma free hemoglobin when used intraoperatively with cardiopulmonary bypass (CPB) in subjects undergoing cardiac surgery.
Subjects must be undergoing cardiac surgery requiring CPB with ananticipated length of CPB greater than or equal to 3 hours.
Barbara Burkott